Table 1.
Disease | Drugs | Selectivity | Effect | Model | Reference |
---|---|---|---|---|---|
AD | CTEP | mGluR5 NAM | Prevents cognitive impairment | APP/PS1 mouse | Lindemann and others 2011; Lindemann and others 2015 |
ASD | JNJ16259685 Fenobam |
mGlu1 antagonist mGlu5 antagonist |
Recue social interaction and repetitive behaviors | Eif4ebp2 knockout mouse | Aguilar-Valles and others 2015; Modi and others 2018 |
ASD | CFMTI | mGluR1 antagonist | Improves social interaction | MK-801 rat | Satow and others 2009 |
Epilepsy |
LY367385 AIDA |
mGluR1 antagonists | Suppress motor seizures | DBA/2 mouse Lethargic mouse Genetically epilepsy-prone rat |
Chapman and others 1999 |
Epilepsy | MPEP SIB-1893 |
mGluR5 antagonists | Suppress clonic seizures | DBA/2 mouse Lethargic mouse |
Chapman and others 2000 |
Epilepsy | LY456236 | mGluR5 antagonist | Inhibits clonic-tonic seizures Inhibits limbic seizures Decreases behavioral and electrographic seizures Decrease generalized seizures |
DBA/2 mouse SD rat |
Shannon and others 2005 |
PD |
LY367385 MPEP |
mGluR1 antagonist mGluR5 antagonist |
Slow degeneration of dopaminergic
neurons Prevent striatal dopamine depletion Attenuate parkinsonian motor deficits Decrease dyskinesia |
6-OHDA rodent MPTP monkey Parkinsonian rat and monkey |
Aguirre and others 2001; Ambrosi and others 2010; Breysse and others 2003; Dekundy and others 2006; Johnston and others 2010; Mela and others 2007; Rylander and others 2010; Vernon and others 2007 |
PD | MTEP | mGluR5 NAM | Reduces neurodegeneration | MPTP non-human primate | Masilamoni and others 2011 |
PD | Fenobam | mGluR5 NAM | Reduces dyskinesia | 6-OHDA rat MPTP monkey |
Ko and others 2014; Rylander and others 2010 |
PD | Dipraglurant | mGluR5 NAM | Reduces severity of dyskinesia | MPTP macaque PD patient |
Bezard and others 2014; Tison and others 2016 |
PD | AFQ056-mavoglurant ADX-48621-dipraglurant |
mGluR5 antagonists | Reduce dyskinesia | PD patient | Stocchi and others 2013 |
HD | MPEP | mGluR5 antagonist | Increases survival time Improves rotarod performance |
R6/2 mouse | Schiefer and others 2004 |
HD | CDPPB | mGlu5 PAM | Prevents neuronal loss Decreases htt aggregation Ameliorates motor incoordination Rescues memory deficit |
BACHD mouse | Doria and others 2015 |
HD | MTEP | mGlu5 NAM | Increases locomotor activity | HdhQ111/Q111 HD mouse | Ribeiro and others 2014 |
ID | CTEP | mGlu5 NAM | Prolongs lifespan Reduces long breath-holding Ameliorates inhibitory avoidance deficit |
Fmr1 KO mouse | Tao and others 2016 |
RTT | CTEP | mGlu5 NAM | Improves lifespan | Mecp2 KO mice | Tao and others 2016 |
Ischemia | MPEP CHPG |
mGluR5 antagonist mGluR5 agonist |
Reduce infarct volume | MCAO rat | Bao and others 2001 |
Depression | MPEP MTEP GRN-529 Basimglurant DSR-98776 |
mGlu5 NAM | Antidepressant action | MDD rat MDD patient |
Chaki and Fukumoto 2018 |